Matches in Wikidata for { <http://www.wikidata.org/entity/Q99355647> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q99355647 description "2020 թվականի սեպտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q99355647 description "article scientifique publié en 2020" @default.
- Q99355647 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99355647 description "scientific article published on 11 September 2020" @default.
- Q99355647 description "wetenschappelijk artikel" @default.
- Q99355647 description "наукова стаття, опублікована 11 вересня 2020" @default.
- Q99355647 name "Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung Cancer" @default.
- Q99355647 name "Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung Cancer" @default.
- Q99355647 type Item @default.
- Q99355647 label "Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung Cancer" @default.
- Q99355647 label "Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung Cancer" @default.
- Q99355647 prefLabel "Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung Cancer" @default.
- Q99355647 prefLabel "Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung Cancer" @default.
- Q99355647 P1433 Q99355647-4656C437-2232-490E-92CA-4ACDFC0933EF @default.
- Q99355647 P1476 Q99355647-1C90E4D5-4D89-42D6-A859-69B94B85FC75 @default.
- Q99355647 P2093 Q99355647-296BBE5D-8442-462F-B6F7-09D742F786B8 @default.
- Q99355647 P2093 Q99355647-30252866-C773-4764-BC34-4C21EC410C6E @default.
- Q99355647 P2093 Q99355647-3E2DB089-8DA1-4B8C-8BA2-F77166EB7CFF @default.
- Q99355647 P2093 Q99355647-44AA5FD7-9093-4186-97C5-9C823C1CC177 @default.
- Q99355647 P2093 Q99355647-778F96EA-4106-4DF3-9A4F-2D06B02623ED @default.
- Q99355647 P2093 Q99355647-9BCEA4AD-AA43-4C82-A28F-C961BD320725 @default.
- Q99355647 P2093 Q99355647-A390C068-1724-4E06-B700-32EC7764C1FA @default.
- Q99355647 P2093 Q99355647-A8850DAE-F19A-454F-82EB-21F4F6317E9F @default.
- Q99355647 P2093 Q99355647-C2728361-E65E-4F6E-AD1C-D626E300E3EF @default.
- Q99355647 P304 Q99355647-440C6457-8B41-445C-84AD-D6E1581D1AB4 @default.
- Q99355647 P31 Q99355647-0F315B59-F409-43E9-AE23-53859CF349B0 @default.
- Q99355647 P356 Q99355647-DD23788F-C8E0-48A7-A992-94A9F8C477E6 @default.
- Q99355647 P577 Q99355647-F1626B70-CFF3-4B51-8497-C7B5D14E24B3 @default.
- Q99355647 P698 Q99355647-0892AC96-0362-465E-8BBE-79D329BCB4A2 @default.
- Q99355647 P921 Q99355647-E3B8A493-9086-42B1-AAE5-0D34A5BEA1DE @default.
- Q99355647 P356 OP.20.00489 @default.
- Q99355647 P698 32915710 @default.
- Q99355647 P1433 Q6295683 @default.
- Q99355647 P1476 "Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung Cancer" @default.
- Q99355647 P2093 "Chantal Cotter" @default.
- Q99355647 P2093 "Daniel Creamer" @default.
- Q99355647 P2093 "Jonathan Handy" @default.
- Q99355647 P2093 "Kara Heelan" @default.
- Q99355647 P2093 "Katherina Bernadette Sreter" @default.
- Q99355647 P2093 "Sanjay Popat" @default.
- Q99355647 P2093 "Sarah Walsh" @default.
- Q99355647 P2093 "Tanya N Basu" @default.
- Q99355647 P2093 "Wanyuan Cui" @default.
- Q99355647 P304 "OP2000489" @default.
- Q99355647 P31 Q13442814 @default.
- Q99355647 P356 "10.1200/OP.20.00489" @default.
- Q99355647 P577 "2020-09-11T00:00:00Z" @default.
- Q99355647 P698 "32915710" @default.
- Q99355647 P921 Q13896859 @default.